Oxford and Serum Institute of India sign IP license agreement to advance NipahB vaccine candidate

Published on March 13, 2026

The University of Oxford and Serum Institute of India Pvt. Ltd. (SII), a Cyrus Poonawalla Group company and the world’s largest vaccine manufacturer, have signed an Intellectual Property license agreement to advance the development and manufacture of the ChAdOx1 NipahB vaccine candidate.
Continue reading on website
Other news

Researchers reveal a new class of molten planet

March 12, 2026
A study led by the University of Oxford has identified a new type of planet beyond our Solar System – one that stores large amounts of sulphur deep within a permanent ocean of magma. The findings have been published today in Nature Astronomy.

New research reveals why some oesophageal cancers are so hard to treat

March 13, 2026
Research published in Science Advances has uncovered new insights into why the most aggressive oesophageal cancers are so difficult to treat and how the body’s own defence systems are helping them to thrive.